Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q422185> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- Q422185 subject Q6814466.
- Q422185 subject Q8217262.
- Q422185 subject Q8343807.
- Q422185 subject Q8412954.
- Q422185 subject Q8808791.
- Q422185 subject Q9546190.
- Q422185 abstract "Enalapril (marketed as Vasotec in the US, Enaladex and Renitec in some other countries, and Enacard for veterinary use) is an angiotensin-converting-enzyme (ACE) inhibitor used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure. ACE converts the peptide hormone angiotensin I to angiotensin II. One of the actions of angiotensin II is the vasoconstriction of blood vessels, resulting in an increase in blood pressure. ACE inhibitors such as enalapril prevent this effect. Enalapril has been shown to lower the death rate in systolic heart failure. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.".
- Q422185 atcPrefix "C09".
- Q422185 atcSuffix "AA02".
- Q422185 bioavailability "60.0".
- Q422185 casNumber "75847-73-3".
- Q422185 chEBI "4784".
- Q422185 drugbank "DB00584".
- Q422185 fdaUniiCode "69PN84IO1A".
- Q422185 iupacName "(2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid".
- Q422185 pubchem "5388962".
- Q422185 thumbnail Enalapril_structure.svg?width=300.
- Q422185 wikiPageExternalLink 10884359.article.
- Q422185 wikiPageExternalLink lookup.cfm?setid=08f90170-f53c-4272-92ae-951cf115e271.
- Q422185 wikiPageWikiLink Q101487.
- Q422185 wikiPageWikiLink Q1054718.
- Q422185 wikiPageWikiLink Q1057079.
- Q422185 wikiPageWikiLink Q11000047.
- Q422185 wikiPageWikiLink Q1129007.
- Q422185 wikiPageWikiLink Q1144406.
- Q422185 wikiPageWikiLink Q14859647.
- Q422185 wikiPageWikiLink Q14863991.
- Q422185 wikiPageWikiLink Q181754.
- Q422185 wikiPageWikiLink Q220410.
- Q422185 wikiPageWikiLink Q247489.
- Q422185 wikiPageWikiLink Q288280.
- Q422185 wikiPageWikiLink Q37155.
- Q422185 wikiPageWikiLink Q41861.
- Q422185 wikiPageWikiLink Q421119.
- Q422185 wikiPageWikiLink Q426660.
- Q422185 wikiPageWikiLink Q5209305.
- Q422185 wikiPageWikiLink Q5375179.
- Q422185 wikiPageWikiLink Q6814466.
- Q422185 wikiPageWikiLink Q736715.
- Q422185 wikiPageWikiLink Q8217262.
- Q422185 wikiPageWikiLink Q8343807.
- Q422185 wikiPageWikiLink Q8412954.
- Q422185 wikiPageWikiLink Q8808791.
- Q422185 wikiPageWikiLink Q9546190.
- Q422185 atcPrefix "9.0".
- Q422185 atcSuffix "AA02".
- Q422185 bioavailability "60.0".
- Q422185 casNumber "75847".
- Q422185 chebi "4784".
- Q422185 drugbank "DB00584".
- Q422185 iupacName "-1".
- Q422185 pubchem "5388962".
- Q422185 unii "69".
- Q422185 type ChemicalSubstance.
- Q422185 type Drug.
- Q422185 type ChemicalObject.
- Q422185 type Thing.
- Q422185 type Q8386.
- Q422185 comment "Enalapril (marketed as Vasotec in the US, Enaladex and Renitec in some other countries, and Enacard for veterinary use) is an angiotensin-converting-enzyme (ACE) inhibitor used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure. ACE converts the peptide hormone angiotensin I to angiotensin II. One of the actions of angiotensin II is the vasoconstriction of blood vessels, resulting in an increase in blood pressure.".
- Q422185 label "Enalapril".
- Q422185 depiction Enalapril_structure.svg.